Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Redshift Horizons deferred consideration payment

28 Feb 2014 07:00

RNS Number : 1438B
First Derivatives PLC
28 February 2014
 



 

First Derivatives plc

("First Derivatives" or the "Company")

 

Redshift Horizons payment of Deferred Consideration

 

First Derivatives (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services to the capital markets industry, announced on 28 September 2012 the acquisition of Cowrie Financial Limited and Redshift Horizons.

 

Under the terms of the acquisition deferred consideration, in the form of a conditional loan note (the "Deferred Consideration Loan Note"), is to be paid subject to certain performance conditions. These performance conditions have been met, thereby requiring the Deferred Consideration Loan Note to be repaid to the vendors in full. In accordance with the terms of the acquisition agreement the Deferred Consideration Loan Note is to be settled through the issue of 55,622 new ordinary shares (the "New Ordinary Shares").

 

Application has been made for the 55,622 New Ordinary Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 5 March 2014.

 

The New Ordinary Shares will rank pari passu with the existing shares of the Company and will represent approximately 0.28 per cent of the enlarged issued share capital. Following the allotment of the New Ordinary Shares the total issued share capital of the Company will increase to 19,541,610 ordinary shares.

 

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive Officer

www.firstderivatives.com

Graham Ferguson, Finance Director

Charles Stanley Securities

+44 (0)20 7149 6000

(Nominated Adviser& Broker)

Russell Cook

Carl Holmes

GoodbodyCorporate Finance

+353 1 667 0420

(ESM Adviser)

Finbarr Griffin

Goodbody Stockbrokers

Linda Hickey

Walbrook PR

+44 (0)20 7933 8780

Financial PR

bob.huxford@walbrookpr.com

Bob Huxford

helen.westaway@walbrookpr.com

Helen Cresswell

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With almost 17 years' experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 850 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQDLFLZLFXBBF
Date   Source Headline
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.